India is the world’s fourth largest producer of pharmaceuticals, and is internationally considered to be one of its most promising biotech markets. Since the reintroduction of patent protection laws for pharmaceutical products in 2005, the subcontinent is increasingly opening up to foreign companies. At the same time, Indian investors are putting money into development at home – for example in the market for biosimilars – with the long-term goal of gaining a foothold in Europe and the rest of the developed world.
According to its own statistics, Japan is the second largest healthcare market in the world after the US. The pharmaceuticals market there has been traditionally dominated by established companies supported by a small number of innovative spin-offs and biotech firms. But as the pressure to change increases in the sector in Japan, the importance of cooperation between pharma companies and specialised biotech firms has likewise grown – and Germany’s biotech sector can profit from it.
Programme
Time Title / Speaker From 12:45 Snack
1:30 – 1:40 p.m. Welcome Address BIO.NRW
Dr. Bernward Garthoff, Chair of Cluster Biotechnolog, North Rhine-Westphalia
1:40 – 2:30 p.m. The View from Inside: Options for German Biotech Companies in India Narayan Seshadri, Chairman and Managing Director, Halcyon Consultants
2:30 – 3:00 p.m. Biotechnology in Japan Nikolaus Raupp, Japan Desk, Association of German Biotechnology Companies
3:00 – 3:15 p.m. Discussion
3:15 – 3:30 p.m. Break for coffee and tea
3:30 – 4:00 p.m. Cooperation Experiences in India and Japan from a Commercial Point of View, N.N.
4:00 – 4:15 p.m. Discussion
4:15 – 4:40 p.m. Successful Market Entry in the Economic Powerhouse of India Dr. Atul K. Gupta, GECgroup GmbH, Duesseldorf
4:40 – 5:05 p.m. Support Measures and How
They Apply to Cooperations in India (and Japan) Verena Müller, International Office of the German Ministry for Research and Education Get-together Speakers
Along with an overview of the markets and research focal points, the workshop will inform participants about possibilities for cooperation and support measures in both India and Japan. The speakers in the programme are acquainted with investor perspectives in the Indian biotech sector (Narayan Seshadri, Halcyon Consultants) or have gained their insights in setting up best practice measures in cooperation with Indian and Japanese firms and research teams. Possibilities for acquiring local support will be presented both from the viewpoint of consultants (Dr. Atul K. Gupta, GECgroup GmbH) and the German Ministry of Research and Education. Workshop Goals.
The “Asian Biotech Hotspots” event will provide information on the Indian and Japanese biotech sectors, as well as respective cooperation and funding possibilities. At the same time, it will serve as a preparatory step for the official BIO.NRW visit of North Rhine-Westphalia’s biotech companies to the Bangalore INDIA BIO in June of 2010 and the BIOEurope 2011 in Duesseldorf. The workshop is aimed at those active in business management and development in North Rhine-Westphalia’s biotech sector.
Registration fee
Participants must pay a registration fee of Euro 29 (not including VAT) to take part in the event.
Venue
Maritim Hotel Duesseldorf
Maritim-Platz 1
40474 Duesseldorf
Registration
Please submit your registration request in writing by April 23rd, 2010. Send the request via email to: bio.academy.nrw(at)bioriver.de. We will send you a confirmation of your registration and an invoice.
Kontakt
Dr. Frauke Hangen, BioRiver e.V.
Tel.: +49-(0)211-316 0610
E-Mail: info(at)bioriver.de
